Perrigo Ordinary Shares reported $4.23B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Aphria Inc APH:CN C$ 730.7M 38.56M
Bayer BAYN:GR 31.94B 506M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Catalent CTLT:US $ 3931M 1013M
Coherus Biosciences CHRS:US $ 673.04M 13.03M
Corcept Therapeutics CORT:US $ 401.9M 9.37M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Horizon Pharma HZNP:US $ 2413.92M 238.54M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Lannett LCI:US $ 364.89M 11.33M
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Perrigo Ordinary Shares PRGO:US $ 4225.9M 194.3M
Phibro Animal Health PAHC:US $ 498.63M 0.28M
Prestige Brands PBH:US $ 304.81M 103.71M
Supernus Pharmaceuticals SUPN:US $ 668.38M 29.13M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Xeris Pharmaceuticals Inc XERS:US $ 124.37M 20.22M
Zoetis ZTS:US $ 6682M 366M